{"symbol":"BSX","fiscalQuarter":"Q2-2013","reportDate":"2013-07-25","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2013","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 12.7%","keyNumbers":[{"metric":"EPS","actual":"$0.18","expected":"N/A","surprise":"+13.21%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product segments.","They noted ongoing investments in innovation to drive future growth."],"summary":"Overall, management expressed confidence in the company's strategic direction. They emphasized their commitment to enhancing product offerings."},"guidanceChanges":{"summary":"No guidance data was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 12.7% increase. The strong EPS performance indicates effective cost management and possibly better-than-expected sales in certain areas. However, the lack of revenue data and guidance leaves some uncertainty about future performance.","metaDescription":"Boston Scientific (BSX) Q2 2013 earnings: EPS beat expectations. Stock up 12.7%. Full breakdown."}}